InfuSystem Holdings, Inc. (NYSE:INFU) Shares Acquired by Minerva Advisors LLC

Key Points

• Minerva Advisors LLC increased its stake in InfuSystem Holdings by 7.5%, making InfuSystem the 8th largest holding in their portfolio.
• Several institutional investors, including BNP Paribas Financial Markets and Wells Fargo & Company, significantly boosted their investments in InfuSystem during the fourth quarter.
• InfuSystem's stock is currently trading at $5.60, down 1.9% with a 52-week range from $4.61 to $9.97.

Minerva Advisors LLC raised its holdings in InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) by 7.5% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 910,677 shares of the company's stock after acquiring an additional 63,826 shares during the quarter. InfuSystem accounts for about 3.0% of Minerva Advisors LLC's holdings, making the stock its 8th biggest position. Minerva Advisors LLC owned about 4.33% of InfuSystem worth $4,899,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. Sei Investments Co. acquired a new position in shares of InfuSystem in the fourth quarter worth $90,000. JPMorgan Chase & Co. raised its holdings in shares of InfuSystem by 283.5% in the fourth quarter. JPMorgan Chase & Co. now owns 59,662 shares of the company's stock worth $504,000 after acquiring an additional 44,106 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of InfuSystem by 1.8% in the fourth quarter. Geode Capital Management LLC now owns 444,476 shares of the company's stock worth $3,756,000 after acquiring an additional 7,968 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of InfuSystem by 51.7% in the fourth quarter. Wells Fargo & Company MN now owns 9,286 shares of the company's stock worth $78,000 after acquiring an additional 3,165 shares during the last quarter. Finally, Renaissance Technologies LLC raised its holdings in shares of InfuSystem by 2.6% in the fourth quarter. Renaissance Technologies LLC now owns 337,609 shares of the company's stock worth $2,853,000 after acquiring an additional 8,700 shares during the last quarter. Institutional investors and hedge funds own 71.13% of the company's stock.

InfuSystem Trading Up 4.4%

Shares of INFU stock traded up $0.26 on Tuesday, reaching $6.11. 241,049 shares of the stock were exchanged, compared to its average volume of 151,415. The stock has a market cap of $128.30 million, a P/E ratio of 101.85 and a beta of 1.81. The company has a quick ratio of 1.59, a current ratio of 1.98 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $5.95 and a two-hundred day moving average of $6.17. InfuSystem Holdings, Inc. has a 1-year low of $4.61 and a 1-year high of $9.97.

Analysts Set New Price Targets

INFU has been the subject of a number of analyst reports. Roth Capital started coverage on InfuSystem in a report on Tuesday, July 22nd. They issued a "buy" rating and a $12.00 price target for the company. Wall Street Zen cut InfuSystem from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 14th. Finally, B. Riley upgraded InfuSystem to a "strong-buy" rating in a report on Thursday, May 8th.

InfuSystem Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.